Skip to main content

AZN · Astrazeneca PLC · Metrics

Track AZN — free
$184.02 -0.43 (-0.23%) At close · Nov 16 Q1 2026 earnings call transcript
Market Cap
$285.40B
Shares
1.55B
Volume · Nov 16 1.95M Avg daily vol (3M) 3.03M

AZN metrics

85 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$184.02
Market cap
$285.40B

Price action

23 metrics
Price change (1W)
-1.1%
Price change (30D)
+12.5%
Price change (3M)
+17.9%
Price change (6M)
+1.6%
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
$209.48
52-week low
$155.62
Change from 52-week high
-11.9%
Change from 52-week low
+18.5%
Annualized volatility
29.4%
Annualized volatility (3M)
27.4%
Implied volatility (30D)
23.0%
IV rank (1Y)
9.8
IV percentile (1Y)
6.0
Beta
0.1
RSI (14D)
61.9
Price vs SMA 50
+9.3%
Price vs SMA 200
—
Avg volume (3M)
3.05M
Relative volume
0.6
Average dollar volume
$511.55M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
1.55B

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
5.0×
reciprocal yield 19.9%
EV / EBITDA
—
EV / EBIT
22.1×
reciprocal yield 4.5%
P / sales
4.7×
reciprocal yield 21.5%
P / book
5.7
reciprocal yield 17.6%
FCF yield
3.7%
TTM · current market cap
Buyback yield
0.2%
P / FCF
26.8
reciprocal yield 3.7%
P / operating cash flow
20.9
reciprocal yield 4.8%
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
1.2%
Trailing 12 months
Payout ratio
46.9%
Shareholder yield
2.0%
Dividend / share (TTM)
$2.15
Dividend growth YoY
-31.2%
Dividend growth streak
2
Last ex-dividend
2026-02-19

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-30

Profitability

9 metrics
Gross margin
81.9%
Operating margin
22.8%
Trailing 12 months
Net margin
17.0%
Gross profit (TTM)
$50.25B
Operating profit (TTM)
$13.97B
Net income (TTM)
$10.45B
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
17.4%
Effective tax rate
16.9%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+6.4%
Year over year
Net income growth YoY
+2.3%
Revenue (TTM)
$61.37B
Trailing 12 months
EPS growth YoY
+2.5%
Shares change YoY
—
Year over year · more shares
Revenue CAGR (3Y)
+9.8%
Revenue CAGR (5Y)
+17.2%
EPS CAGR (3Y)
+15.7%
EPS CAGR (5Y)
+6.0%
FCF CAGR (3Y)
+10.5%
FCF CAGR (5Y)
+25.1%

Quality

14 metrics
Return on equity
20.8%
Return on assets
9.0%
Debt / equity
0.6
Current ratio
0.9
EBITDA (TTM)
—
Free cash flow (TTM)
$10.67B
Quick ratio
0.7
Interest coverage
8.0
Net debt / EBITDA
—
Return on invested capital
16.4%
Trailing 12 months
Net cash
−$22.11B
Latest balance sheet
Cash & equivalents
$5.71B
Total assets
$115.83B
Total debt
$27.82B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$13.70B
Capital expenditures (TTM)
$3.03B
R&D (TTM)
$15.07B
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
24.6%
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
1,227
13F filer change QoQ
-260
Institutional ownership
45.7%
Conviction holders (share of 13F filers)
3.2%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+1.1%
Holder tenure
2.9
Price vs estimated holder cost
-7.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.2%

Short interest

3 metrics
Short interest
0.2%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
45 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 901832 CUSIP G0593M107 13F (30d) 1094 filings 1075 filers Visit website Investor relations